Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
Just think: if you consistently nourished your body with only processed or fast foodswithout eating any fruits, vegetables, or high-quality proteinyour workouts and your overall health would likely suffer
Oral Formulations: Traditionally injectable, new oral GLP-1 formulations are in development
Track your bets with timestamps and closing lines, segment your performance by sport and market type, and set preplanned stop-loss points so decisions are never made under stress
Liposomal, intravenous, or intranasal forms offer higher systemic delivery